Werkgroep Cardiologische centra Nederland English

DECLARE TIMI 58 (Follow up)

Dapagliflozin Effect on Cardiovascular Events.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes.

Middel
dapagliflozin
Populatie
preventie (diabetes)
Fase
III
Jaar aanvang
2013
Meer informatie
ClinicalTrials.gov